Erschienen in:
01.12.2017 | Original Article
Improving patient outcomes in fibrous dysplasia/McCune-Albright syndrome: an international multidisciplinary workshop to inform an international partnership
verfasst von:
A. M. Boyce, A. Turner, L. Watts, L. Forestier-Zhang, A. Underhill, R. Pinedo-Villanueva, F. Monsell, D. Tessaris, C. Burren, L. Masi, N. Hamdy, M. L. Brandi, R. Chapurlat, M. T. Collins, Muhammad Kassim Javaid
Erschienen in:
Archives of Osteoporosis
|
Ausgabe 1/2017
Einloggen, um Zugang zu erhalten
Abstract
Summary
To develop consensus on improving the management of patients, we convened an international workshop involving patients, clinicians, and researchers. Key findings included the diagnostic delay and variability in subsequent management with agreement to develop an international natural history study. We now invite other stakeholders to join the partnership.
Purpose
The aim of this study was develop a consensus on how to improve the management of patients with fibrous dysplasia and prioritize areas for research
Methods
An international workshop was held over 3 days involving patients, clinicians, and researchers. Each day had a combination of formal presentations and facilitated discussions that focused on clinical pathways and research.
Results
The patient workshop day highlighted the variability of patients’ experience in getting a diagnosis, the knowledge of general clinical staff, and understanding long-term outcomes. The research workshop prioritized collaborations that improved understanding of the contemporary natural history of fibrous dysplasia/McCune-Albright syndrome (FD/MAS). The clinical workshop outlined the key issues around diagnostics, assessment of severity, treatment and monitoring of patients.
Conclusions
In spite of advances in understanding the genetic and molecular underpinnings of fibrous dysplasia/McCune-Albright syndrome, clinical management remains a challenge. From the workshop, a consensus was reached to create an international, multi-stakeholder partnership to advance research and clinical care in FD/MAS. We invite other stakeholders to join the partnership.